Acorah Software Products - Accounts Production 16.5.460 false true 31 March 2024 1 April 2023 false 1 April 2024 31 March 2025 31 March 2025 10741773 Mr Patrick Wallace Mr Benjamin Weatherall Mr Jody O'Neill iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10741773 2024-03-31 10741773 2025-03-31 10741773 2024-04-01 2025-03-31 10741773 frs-core:CurrentFinancialInstruments 2025-03-31 10741773 frs-core:Non-currentFinancialInstruments 2025-03-31 10741773 frs-core:SharePremium 2025-03-31 10741773 frs-core:ShareCapital 2025-03-31 10741773 frs-core:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31 10741773 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 10741773 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10741773 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 10741773 frs-bus:SmallEntities 2024-04-01 2025-03-31 10741773 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 10741773 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 10741773 frs-bus:OrdinaryShareClass1 2024-04-01 2025-03-31 10741773 frs-bus:OrdinaryShareClass1 2025-03-31 10741773 frs-core:CostValuation 2024-03-31 10741773 frs-core:AdditionsToInvestments 2025-03-31 10741773 frs-core:CostValuation 2025-03-31 10741773 frs-core:ProvisionsForImpairmentInvestments 2024-03-31 10741773 frs-core:ProvisionsForImpairmentInvestments 2025-03-31 10741773 frs-bus:Director1 2024-04-01 2025-03-31 10741773 frs-bus:Director2 2024-04-01 2025-03-31 10741773 frs-bus:Director3 2024-04-01 2025-03-31 10741773 frs-countries:EnglandWales 2024-04-01 2025-03-31 10741773 2023-03-31 10741773 2024-03-31 10741773 2023-04-01 2024-03-31 10741773 frs-core:CurrentFinancialInstruments 2024-03-31 10741773 frs-core:Non-currentFinancialInstruments 2024-03-31 10741773 frs-core:SharePremium 2023-03-31 10741773 frs-core:SharePremium 2024-03-31 10741773 frs-core:ShareCapital 2023-03-31 10741773 frs-core:ShareCapital 2024-03-31 10741773 frs-core:RetainedEarningsAccumulatedLosses 2023-04-01 2024-03-31 10741773 frs-core:RetainedEarningsAccumulatedLosses frs-core:PreviouslyStatedAmount 2023-03-31 10741773 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31 10741773 frs-bus:OrdinaryShareClass1 2023-04-01 2024-03-31
Registered number: 10741773
Ecare Group Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2025
Andrew Lillingston Limited
13 Hurlingham Studios
Ranelagh Gardens
London
SW6 3PA
Ecare Group Ltd
Contents
Contents

| Page
--- | ---
Balance Sheet | 1—2
Statement of Changes in Equity | 3
Notes to the Financial Statements | 4—5

Page 1
Ecare Group Ltd
Balance Sheet
As At 31 March 2025
Balance Sheet
Registered number: 10741773

| 2025 | 2024 as restated
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Investments | 4 |  | 1,103 |  | 101
|  |  | 1,103 |  | 101
CURRENT ASSETS
Debtors | 5 | 11,925,027 |  | 10,960,552 |
Cash at bank and in hand |  | 114,154 |  | 5,304 |
|  | 12,039,181 |  | 10,965,856 |
Creditors: Amounts Falling Due Within One Year | 6 | (89,742 ) |  | (147,184 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 11,949,439 |  | 10,818,672
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 11,950,542 |  | 10,818,773
Creditors: Amounts Falling Due After More Than One Year | 7 |  | (68,554 ) |  | (50,000 )
NET ASSETS |  |  | 11,881,988 |  | 10,768,773
CAPITAL AND RESERVES
Called up share capital | 8 |  | 210 |  | 191
Share premium account |  |  | 11,592,829 |  | 10,400,860
Profit and Loss Account |  |  | 288,949 |  | 367,722
SHAREHOLDERS' FUNDS |  |  | 11,881,988 |  | 10,768,773

Page 1
Page 2
Ecare Group Ltd
Balance Sheet (continued)
As At 31 March 2025
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Mr Benjamin Weatherall Director
07/11/2025

The notes on pages 4 to 5 form part of these financial statements.
Page 2
Page 3
Ecare Group Ltd
Statement of Changes in Equity
For The Year Ended 31 March 2025
Statement of Changes in Equity

| Share Capital | Share Premium | Profit and Loss Account | Total
--- | --- | --- | --- | ---
| £ | £ | £ | £
As at 1 April 2023 | 180 | 8,471,892 | 396,687 | 8,868,759
Loss for the year and total comprehensive income | - | - | (28,965 ) | (28,965)
Arising on shares issued during the period | 11 | 1,928,968 | - | 1,928,979
As at 31 March 2024 and 1 April 2024 as restated | 191 | 10,400,860 | 367,722 | 10,768,773
Loss for the year and total comprehensive income | - | - | (78,773 ) | (78,773)
Arising on shares issued during the period | 19 | 1,191,969 | - | 1,191,988
As at 31 March 2025 | 210 | 11,592,829 | 288,949 | 11,881,988

Page 3
Page 4
Ecare Group Ltd
Notes to the Financial Statements
For The Year Ended 31 March 2025
Notes to the Financial Statements
1. General Information
Ecare Group Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 10741773 . The registered office is 18 Ashwin Street, London, England, E8 3DL.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Prior Year Adjustment – Loan Misclassification
During the year, the directors identified that a loan of £50,000 had been incorrectly credited to the share premium account in the prior period. The loan did not meet the criteria for equity classification under FRS 102 Section 22. As a result, the comparative figures have been restated to reclassify the amount as a financial liability. This adjustment has no impact on profit but affects the presentation of equity and liabilities.
2.3. Exemption from preparing consolidated financial statements
The Company, and the Group headed by it, qualify as small as set out in section 383 of the Companies Act 2006 and the parent and Group are considered eligible for the exemption to prepare consolidated accounts.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 3 (2024: 3)
3 3
4. Investments

| Subsidiaries
--- | ---
| £
Cost or Valuation
As at 1 April 2024 | 101
Additions | 1,002
As at 31 March 2025 | 1,103
Provision
As at 1 April 2024 | -
As at 31 March 2025 | -
Net Book Value
As at 31 March 2025 | 1,103
As at 1 April 2024 | 101

5. Debtors

| 2025 |  | 2024 as restated
--- | --- | --- | ---
| £ |  | £
Due within one year
Amounts owed by group undertakings | 11,924,952 |  | 10,960,477
Other debtors | 75 |  | 75
| 11,925,027 |  | 10,960,552

Page 4
Page 5
Ecare Group Ltd
Notes to the Financial Statements (continued)
For The Year Ended 31 March 2025
6. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024 as restated
--- | --- | --- | ---
| £ |  | £
Bank loans and overdrafts | 55,660 |  | 110,149
Other creditors | 34,082 |  | 37,035
| 89,742 |  | 147,184

7. Creditors: Amounts Falling Due After More Than One Year

| 2025 |  | 2024 as restated
--- | --- | --- | ---
| £ |  | £
Bank loans | 18,554 |  | -
Other loans | 50,000 |  | 50,000
| 68,554 |  | 50,000

8. Share Capital

| 2025 |  | 2024 as restated
--- | --- | --- | ---
Allotted, called up and fully paid | £ |  | £
2,099,834 Ordinary Shares of £ 0.0001 each | 210 |  | 191

Shares issued during the period: | £
187,752 Ordinary Shares of £ 0.0001 each | 19

During the year, the company issued 187,752 ordinary shares of £0.0001 each, resulting in an increase in share capital of £18.78 and a share premium of £1,191,969.
Page 5